Cargando…
Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive
Autores principales: | Ewers, Michael, Ioannidis, John P.A., Plesnila, Nikolaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554475/ https://www.ncbi.nlm.nih.gov/pubmed/33068714 http://dx.doi.org/10.1016/j.jclinepi.2020.10.008 |
Ejemplares similares
-
High-cited favorable studies for COVID-19 treatments ineffective in large trials
por: Ioannidis, John P.A.
Publicado: (2022) -
The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war
por: Pacheco, Rafael Leite, et al.
Publicado: (2021) -
Using open data and open-source software to develop spatial indicators of urban design and transport features for achieving healthy and sustainable cities
por: Boeing, Geoff, et al.
Publicado: (2022) -
Clinical trial design and new therapies for pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2019) -
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
por: Menis, Jessica, et al.
Publicado: (2014)